3.13
price down icon4.28%   -0.14
after-market Dopo l'orario di chiusura: 3.11 -0.02 -0.64%
loading
Precedente Chiudi:
$3.27
Aprire:
$3.26
Volume 24 ore:
341.54K
Relative Volume:
0.58
Capitalizzazione di mercato:
$47.02M
Reddito:
-
Utile/perdita netta:
$-64.47M
Rapporto P/E:
-0.506
EPS:
-6.1852
Flusso di cassa netto:
$-52.33M
1 W Prestazione:
-7.12%
1M Prestazione:
-43.81%
6M Prestazione:
-45.09%
1 anno Prestazione:
-84.92%
Intervallo 1D:
Value
$3.10
$3.2999
Intervallo di 1 settimana:
Value
$3.10
$3.48
Portata 52W:
Value
$2.265
$26.05

Jasper Therapeutics Inc Stock (JSPR) Company Profile

Name
Nome
Jasper Therapeutics Inc
Name
Telefono
(650) 549-1400
Name
Indirizzo
2200 BRIDGE PKWY SUITE #102, REDWOOD CITY
Name
Dipendente
64
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
JSPR's Discussions on Twitter

Confronta JSPR con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
JSPR
Jasper Therapeutics Inc
3.13 49.12M 0 -64.47M -52.33M -6.1852
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Jasper Therapeutics Inc Stock (JSPR) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-07-08 Downgrade BMO Capital Markets Outperform → Market Perform
2025-07-08 Downgrade RBC Capital Mkts Outperform → Sector Perform
2025-07-07 Downgrade Cantor Fitzgerald Overweight → Neutral
2025-07-07 Downgrade William Blair Outperform → Mkt Perform
2025-02-13 Iniziato UBS Buy
2024-12-06 Iniziato BMO Capital Markets Outperform
2024-09-09 Iniziato JMP Securities Mkt Outperform
2024-07-08 Iniziato BTIG Research Buy
2024-06-27 Iniziato Stifel Buy
2024-05-06 Iniziato H.C. Wainwright Buy
2024-04-03 Iniziato Evercore ISI Outperform
2024-03-28 Iniziato RBC Capital Mkts Outperform
2024-03-18 Iniziato TD Cowen Outperform
2023-08-11 Iniziato CapitalOne Overweight
2022-02-28 Iniziato Cantor Fitzgerald Overweight
2021-11-08 Iniziato Credit Suisse Outperform
2021-10-21 Iniziato William Blair Outperform
2021-10-20 Iniziato BMO Capital Markets Outperform
2021-10-13 Iniziato Oppenheimer Outperform
Mostra tutto

Jasper Therapeutics Inc Borsa (JSPR) Ultime notizie

pulisher
Jul 24, 2025

When is the best time to buy Jasper Therapeutics Inc. Equity Warrant stockConsistently high yield - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

What drives Jasper Therapeutics Inc. stock priceFree Daily Trading Room Entry - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

Jasper Therapeutics Inc. Equity Warrant Stock Analysis and ForecastBreakthrough stock performance - Autocar Professional

Jul 24, 2025
pulisher
Jul 23, 2025

Is Jasper Therapeutics Inc. a good long term investmentPhenomenal capital appreciation - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Jasper Therapeutics Inc. Equity Warrant stockUnmatched market gains - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Jasper Therapeutics, Inc. (NASDAQ:JSPR) Receives $29.75 Average Target Price from Analysts - Defense World

Jul 23, 2025
pulisher
Jul 23, 2025

Jasper Therapeutics Inc. Stock Analysis and ForecastSkyrocketing profit margins - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

What drives Jasper Therapeutics Inc. Equity Warrant stock priceFree Market Volatility Navigation Tips - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is Jasper Therapeutics Inc. Equity Warrant a good long term investmentFree Stock Market Return Analysis - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Jasper Therapeutics Inc. stockMarket-beating performance - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Jasper Therapeutics, Inc.JSPR - WV News

Jul 22, 2025
pulisher
Jul 20, 2025

Trading (JSPR) With Integrated Risk Controls - news.stocktradersdaily.com

Jul 20, 2025
pulisher
Jul 19, 2025

Layoff Tracker: Following Challenges With DMD Therapy, Sarepta Will Cut 500 Employees - BioSpace

Jul 19, 2025
pulisher
Jul 18, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Jasper Therapeutics, Inc. - GlobeNewswire Inc.

Jul 18, 2025
pulisher
Jul 17, 2025

Jasper Therapeutics’ SWOT analysis: briquilimab stock faces pivotal moment - Investing.com

Jul 17, 2025
pulisher
Jul 15, 2025

Finance Watch: Karyopharm Cuts Jobs In Cash Crunch; Pacira’s Layoffs Attributed To Efficiency - insights.citeline.com

Jul 15, 2025
pulisher
Jul 14, 2025

Bay Area biotech company's drug mishap leads to dozens of layoffs - SFGATE

Jul 14, 2025
pulisher
Jul 14, 2025

HC Wainwright Issues Positive Estimate for JSPR Earnings - Defense World

Jul 14, 2025
pulisher
Jul 12, 2025

Jasper Therapeutics' Data Crisis and the Investor's Dilemma: Fraud or Unfortunate Setback? - AInvest

Jul 12, 2025
pulisher
Jul 12, 2025

Jasper Therapeutics price target lowered to $12 from $70 at Citizens JMP - MSN

Jul 12, 2025
pulisher
Jul 11, 2025

Redwood City's Jasper Therapeutics Valuation Tumbles Amid Clinical Trial Setbacks and Layoffs - Hoodline

Jul 11, 2025
pulisher
Jul 11, 2025

Jasper Therapeutics shares fall 1.99% after-hours as Schall Law Firm investigates securities law violations. - AInvest

Jul 11, 2025
pulisher
Jul 11, 2025

JSPR Investors Have Opportunity to Join Jasper Therapeutics, Inc. Fraud Investigation with the Schall Law Firm - Business Wire

Jul 11, 2025

Jasper Therapeutics Inc Azioni (JSPR) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):